Research programme: inflammation and bacterial infection therapeutics - Bloom Burton and Co./Sirona Biochem
Latest Information Update: 21 Oct 2013
At a glance
- Originator Sirona Biochem - Bloom Burton & Co (JV)
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Bacterial infections; Inflammation
Most Recent Events
- 08 Oct 2013 Early research in Inflammation in Canada (unspecified route)
- 08 Oct 2013 Early research in Bacterial infections in Canada (unspecified route)